Gainers
- Check-Cap (NASDAQ:CHEK) stock rose 149.01% to $3.81 during Monday's pre-market session. The company's market cap stands at $176.1 million.
- Intec Pharma (NASDAQ:NTEC) stock rose 89.52% to $8.7. The market value of their outstanding shares is at $34.3 million.
- Acer Therapeutics (NASDAQ:ACER) stock rose 67.15% to $5.7. The company's market cap stands at $81.5 million.
- Ocuphire Pharma (NASDAQ:OCUP) shares moved upwards by 31.94% to $10.49. The company's market cap stands at $114.6 million.
- GenMark Diagnostics (NASDAQ:GNMK) stock increased by 29.02% to $23.87. The company's market cap stands at $1.7 billion.
- INVO Bioscience (NASDAQ:INVO) shares increased by 24.28% to $6.5. The market value of their outstanding shares is at $62.1 million.
Losers
- Entera Bio (NASDAQ:ENTX) shares decreased by 9.43% to $6.25 during Monday's pre-market session. The market value of their outstanding shares is at $131.6 million.
- Hepion Pharmaceuticals (NASDAQ:HEPA) shares decreased by 6.97% to $2.27. The company's market cap stands at $173.0 million.
- Renalytix AI (NASDAQ:RNLX) stock fell 6.49% to $29.0. The market value of their outstanding shares is at $1.0 billion.
- Eli Lilly (NYSE:LLY) stock fell 6.14% to $195.31. The company's market cap stands at $187.1 billion.
- Second Sight Medical (NASDAQ:EYES) shares decreased by 6.06% to $14.28. The market value of their outstanding shares is at $331.4 million.
- RAPT Therapeutics (NASDAQ:RAPT) shares fell 5.75% to $21.01. The company's market cap stands at $522.4 million. The company's, Q4 earnings came out 2 days ago.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
